Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

28.50
+2.459.40%
Post-market: 28.43-0.0700-0.25%16:54 EDT
Volume:8.65M
Turnover:240.87M
Market Cap:8.04B
PE:76.61
High:28.68
Open:25.80
Low:25.80
Close:26.05
52wk High:34.54
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:2.73
T/O Rate:7.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:13.59
PE(LYR):-8.85

Loading ...

Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95

Reuters
·
May 12

Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler

TIPRANKS
·
May 12

Caris Life Sciences announces publication of study on measuring TMB using WES

TIPRANKS
·
May 12

Caris study finds whole exome TMB predicts pembrolizumab survival better than gene panels

Reuters
·
May 12

Guggenheim Sticks to Their Buy Rating for Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
May 11

Caris Life Sciences submits application to NYSDOH for Caris Assure testing

TIPRANKS
·
May 09

Caris Life Sciences Submits Application for Molecular Profiling Test in New York State

MT Newswires Live
·
May 09

Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization

THOMSON REUTERS
·
May 09

Caris submits NY health department review application for Caris Assure blood test authorization

Reuters
·
May 09

Stock Track | Caris Life Sciences Plummets 15.32% Intraday Despite Earnings Beat on Quarterly Loss and Analyst Estimate Revisions

Stock Track
·
May 08

Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler

TIPRANKS
·
May 08

Guggenheim Sticks to Its Buy Rating for Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
May 08

Caris Life Sciences price target lowered to $28 from $35 at Citi

TIPRANKS
·
May 08

Caris Life Sciences Is Maintained at Buy by BTIG

Dow Jones
·
May 08

CAI Corp Shareholders Unanimously Back Board, Auditor and Capital Mandates at AGM

TIPRANKS
·
May 08

Stock Track | Caris Life Sciences Plunges 9.83% in Pre-market Despite Earnings Beat Amid Quarterly Loss and Estimate Revisions

Stock Track
·
May 08

Stock Track | Caris Life Sciences Plunges 10.28% in Extended Trading Despite Earnings Beat

Stock Track
·
May 08

Analyst Reiterates Buy as Strong Revenue, Improving Profitability Offset Near-Term Risks; Price Target Trimmed to $31

TIPRANKS
·
May 08

Caris Life Sciences Earnings Call Signals Profitable Surge

TIPRANKS
·
May 08

Caris Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08